Tower Research Capital (TRC)’s C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant CXAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6
Closed -$65 6370
2023
Q3
$65 Sell
6
-100
-94% -$1.07K ﹤0.01% 5766
2023
Q2
$1.13K Buy
106
+6
+6% +$64 ﹤0.01% 5458
2023
Q1
$1K Buy
+100
New +$1.03K ﹤0.01% 5704

Tower Research Capital (TRC)'s CXAC.U Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant (CXAC.U) in Q4 2023, closing a stake of 6 shares — an estimated $65 sold.

Tower Research Capital (TRC) first reported a position in CXAC.U in Q1 2023 and held it in 3 quarters. The position peaked at $1.13K in Q2 2023. 0 funds tracked by Wall St. Rank hold CXAC.U as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6 C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant shares in Q4 2023, an estimated $65.
  • Tower Research Capital (TRC) first reported a position in C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant in Q1 2023 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant position peaked at $1.13K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.